ʻO Bifidobacteria

Anter

• E kūpono paha no ...
• ʻAʻole kūpono paha no ...
• ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...
• Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

ʻO Bifidobacteria kahi pūʻulu bacteria e noho maʻamau i nā ʻōpū. Hiki iā lākou ke ulu ma waho o ke kino a laila lawe ʻia e ka waha i lāʻau lapaʻau.

Hoʻohana pinepine ʻia ʻo Bifidobacteria no ka palahī, ka paʻa paʻa ʻana, kahi maʻi ʻōpū i kapa ʻia ʻo ka maʻi huhū huhū, no ka pale ʻana i ke anuanu a me ka maʻi flu, a me nā ʻano ʻano ʻē aʻe he nui, akā ʻaʻohe hōʻike ʻepekema maikaʻi e kākoʻo i ka nui o kēia mau hoʻohana.

ʻO ka maʻi Coronavirus 2019 (COVID-19): ʻAʻohe hōʻike maikaʻi e kākoʻo i ka hoʻohana ʻana i ka bifidobacteria no COVID-19. E hāhai i nā koho nohona olakino a me nā ʻano hana pale i hōʻoia ʻia ma kahi.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no BIFIDOBACTERIA penei:

E kūpono paha no ...

• Konipōpō. Hōʻike ka hapa nui o ka noiʻi ʻana i ka lawe ʻana i ka bifidobacteria hiki ke hoʻonui i ka neʻe ʻana o ka ʻōpū ma kahi o 1.5 mau noho i kēlā me kēia pule i ka poʻe me ka constipation. Akā ʻaʻole like nā ʻano āpau o bifidobacteria.
• ʻO kahi maʻi maʻi digestive e hiki ai i nā ulcer (Helicobacter pylori a i ʻole H. pylori). ʻO ka lawe ʻana i ka bifidobacteria a me ka lactobacillus a me ka maʻamau ʻo H. pylori therapy e kōkua paha e kāpae i nā maʻi H. pylori ma kahi o ʻelua a me ka lawe ʻana i ka maʻamau H. pylori therapy wale nō. Hiki iā ia ke hōʻemi i nā hopena ʻē aʻe e like me ka diarrhea a me ka ʻono maikaʻi ʻole mai ka H. pylori therapy.
• ʻO kahi maʻi lōʻihi lōʻihi o nā ʻōpū nui e hōʻeha i ka ʻeha o ka ʻōpū (irritable bowel syndrome or IBS). Hōʻike ka hapa nui o ka noiʻi ʻana i ka lawe ʻana i ka bifidobacteria no 4-8 mau pule hiki ke hōʻemi i nā hōʻailona IBS e like me ka ʻeha o ka ʻōpū, ka momona, a me ka paʻakikī e loaʻa i ka ʻōpū. Hoʻoemi paha ia i nā ʻōuli e like me ka hopohopo a me ke kaumaha i ka poʻe me IBS. Akā ʻaʻole like nā ʻano āpau o bifidobacteria.
• A komplication ma hope oʻoki kino no ulcerative colitis (pouchitis). Lawe ʻia i ka hui pū ʻana o bifidobacteria a me lactobacillus, me ka ʻole o ka streptococcus, e ka waha me he mea lā ke kōkua ʻana e pale aku i ka pouchitis ma hope o ke kaha ʻana no colitis ulcerative.
• ʻO ka maʻi o nā alaloa. Hōʻike ka hapa nui o ka noiʻi ʻana i ka hoʻohana ʻana i nā probiotics i loko o ka bifidobacteria e kōkua ai i ka pale ʻana i nā maʻi lele e like me ke anuanu maʻamau i nā kānaka olakino ʻē aʻe, me nā keiki kula a me nā haumāna o ke koleke. Akā ʻo ka lawe ʻana i ka bifidobacteria ʻaʻole ia e hōʻemi i ka makaʻu o nā maʻi lele i nā keiki a me nā ʻōpio i ka haukapila a i ʻole nā ​​ʻelemākule e mālama ana.
• Hoʻopilikia ʻia e ka rotavirus. ʻO ka hāʻawi ʻana i ka bifidobacteria i nā pēpē me ka diarrhea rotaviral hiki ke hoʻopōkole i ka lōʻihi o ka pehu ma kahi o hoʻokahi lā.
• ʻO ka maʻi diarrhea. ʻO ka lawe ʻana i ka bifidobacteria kōkua i ka pale ʻana i ka maʻi o ka poʻe huakaʻi ke hoʻohana ʻia me nā probiotics ʻē aʻe e like me lactobacillus a i ʻole streptococcus.
• ʻO kahi ʻano maʻi maʻi ʻōpū (ulcerative colitis). Hōʻike ka noiʻi e lawe ana i nā probiotics i loko o ka bifidobacteria me ka lactobacillus a me ka streptococcus hiki ke kōkua i ka hoʻonui ʻana i ka helu remission ma kahi o 2-pā i nā poʻe me ka colitis ulcerative ʻeleu. Eia nō naʻe, hōʻike ka hapanui o ka noiʻi ʻaʻole pono ka bifidobacteria no ka pale ʻana i ka hoʻi hou.

ʻAʻole kūpono paha no ...

• E hōʻole i ka hoʻomanaʻo a me nā mākau noʻonoʻo e hana maʻamau me ka makahiki. ʻAʻole maikaʻi ka Bifidobacteria e hoʻomaikaʻi ai i ka noʻonoʻo a me ka mākau hoʻomanaʻo i nā mākua makua me ka emi maʻamau o ka noʻonoʻo noʻonoʻo.
• ʻO ka maʻi o ka gastrointestinal tract e nā bacteria i kapa ʻia ʻo Clostridium difficile. ʻO ka hapa nui o nā noiʻi e hōʻike ana i ka lawe ʻana i ka bifidobacteria me nā probiotics ʻē aʻe ʻaʻole ia e pale i ka maʻi palahō na Clostridium difficile maʻi.
• Hoʻomohala pēpē. ʻO ka hāʻawi ʻana i ka haʻilula i loko o ka bifidobacteria me ka lactobacillus ʻaʻole ia e hoʻomaikaʻi i ka ulu ʻana o nā pēpē.
• Ka momona. Hōʻike ka hapa nui o ka noiʻi ʻana i ka lawe ʻana i ka bifidobacteria a hiki i nā mahina 6 ʻaʻole e hoʻomaikaʻi i ka pohō kaumaha o ka poʻe i kaumaha a momona paha.
• Kino maʻi (sepsis). ʻO ka hoʻohui ʻana i ka bifidobacteria i ke ʻano pēpē ʻaʻole ia e pale i ka sepsis ma nā pēpē pēpē.

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

• ʻO ka maʻi pākī i ka poʻe e lawe ana i nā antibiotic (diarrhea antibiotic-pili). Hōʻike ka noiʻi i ka lawe ʻana i ka bifidobacteria me nā antibiotic hiki ke hoʻemi i ka manawa o ka maʻi diarrhea ma kahi o 45%. Akā aia kekahi mau hopena hakakā. Hiki paha i ka bifidobacteria ke pale aku i ka maʻi diarrhea i hoʻokumu ʻia e kekahi lāʻau ʻalopika akā ʻaʻole kekahi. Eia kekahi, ʻoi aku ka maikaʻi o ka bifidobacteria ke hoʻohana ʻia i kekahi mau hui pū me ka lactobacillus a me ka streptococcus. Akā ʻaʻole like ka maikaʻi o ka hui ʻana āpau.
• Hana Athletic. Hōʻike ka noiʻi mua ʻana i ka lawe ʻana i ka bifidobacteria i mea kōkua i ka poʻe ʻaleʻale i hoʻomaʻamaʻa e holo ʻoi aku i ka manawa like.
• Eczema (atopic dermatitis). Hōʻike kekahi mau noiʻi e hāʻawi ana i ka bifidobacterium i nā pēpē i hiki ke kōkua iā TREAT eczema, akā aia nā hopena hakakā. Hōʻike nā noiʻi ʻē aʻe i ka hāʻawi ʻana i ka bifidobacteria a me ka lactobacillus i nā wahine hāpai i nā mahina 2 i hala o ka hāpai ʻana, a laila hāʻawi i ke keiki pēpē no nā mahina 2 ma hope o ka hānau ʻana, hiki ke kōkua iā PREVENT eczema. Akā loaʻa nā hopena hakakā. ʻO ka hāʻawi ʻana i ka bifidobacteria a me ka lactobacillus i nā kamaliʻi makaʻu ʻole wale nō i nā mahina 6 mua o ke ola, ʻaʻole ia e pale i ka eczema.
• Maʻi Celiac. Hōʻike ka noiʻi mua ʻana i ka lawe ʻana i ka bifidobacteria ma ke ʻano he papaʻai gluten-ʻole e hoʻomaikaʻi ai i ka ʻōpū a me nā ʻōpū o ka ʻōpū ke hoʻohālikelike ʻia i ka papaʻai wale nō i nā keiki me ka maʻi celiac hou i hōʻike ʻia.
• E hōʻole i ka hoʻomanaʻo a me ka noʻonoʻo noʻonoʻo i ka poʻe kahiko ʻoi aku ma mua o ka mea maʻamau no ko lākou mau makahiki. Hōʻike kekahi mau noiʻi e lawe ana i ka bifidobacteria e hoʻomaikaʻi ai i ka hoʻomanaʻo i ka poʻe me ka emi o ka noʻonoʻo noʻonoʻo, akā ʻaʻole ia he mea kōkua me ka ʻōlelo a i ʻole ka hiki ke hoʻolohe.
• Paka niho. Hōʻike ka noiʻi mua i ka ʻai ʻana i ka yogurt hua me bifidobacteria no 2 mau pule ʻaʻole e hoʻēmi i ka pā niho i nā keiki.
• Pohā. Ua ʻike ʻia ka noiʻi mua ʻana e hoʻohui ana ka bifidobacteria i Saccharomyces boulardii e hoʻoliʻiliʻi hou ʻia ai ka maʻi diarrhea i nā keiki me ka hikiwawe o ka diarrhea.
• ʻAla i ka pollen kedera Iapana. Hōʻike kekahi mau noiʻi e lawe ana i ka bifidobacteria i ka wā o ka pollen e hoʻoliʻiliʻi ai ka ihu a me nā ʻōuli o ka maka o ka Japanese alerine pollen. Akā loaʻa nā hopena hakakā. ʻAʻole hiki i ka Bifidobacteria ke hōʻemi i ka hiʻu a i ʻole nā ​​ʻōuli o ka ʻāʻī e pili ana me ka allergy polen i Kepani Kepani.
• ʻO kahi maʻi ʻōpū nui i nā pēpē premature (nekrotizing enterocolitis a i ʻole NEC). Hōʻike ka noiʻi ʻaʻole e pale i ka hāʻawi ʻana i nā bifidobacteria wale nō i nā pēpē preterm i kēia ʻano. Akā ʻo ka hāʻawi ʻana i ka bifidobacteria me ka lactobacillus he mea liʻiliʻi paha ia.
• Maʻi nui i hoʻokumu ʻia e ka pāhawewe. Hōʻike ka noiʻi mua i hiki i nā antibiotic-resistive bifidobacteria ke kōkua i ka hoʻomaikaʻi ʻana i ke ola pōkole i ka mālama ʻana i ka maʻi radiation. I ka hui pū ʻana me nā lāʻau ʻalopika, ʻike ʻia ka bifidobacteria e kōkua ai i ka pale ʻana i nā koʻohune weliweli mai ka ulu ʻana a hiki i kahi maʻi nui.
• Rheumatoid arthritis (RA).
• Nā maʻi o ke kīhā, ka pūpū, a i ʻole ka urethra (nā maʻi maʻi urinary tract a i ʻole UTIs).
• ʻElemakule.
• Uha ʻeha, ma muli paha o ka maʻi (mastitis).
• Kanesa.
• Bipolar kāna hana.
• Nā maʻi i nā poʻe i mālama ʻia me nā lāʻau ʻaʻai.
• Hoʻolālā keiki.
• Ka ulu a me ka hoʻomohala ʻana i nā pēpē premature.
• Hoʻoemi ʻia a ālai ʻia o ke kahe mai ke ake (cholestasis).
• Diabetes.
• Ka hoʻomanawanui ʻole ʻana i ka lactose.
• Nā pilikia ate.
• Maʻi Lyme.
• Puʻupuʻu.
• ʻO ka ʻehaʻeha o ka mākau ma muli o ka hoʻoikaika kino.
• Nā pae kiʻekiʻe o ke kolesterol a i ʻole nā ​​momona ʻē aʻe (lipids) i ke koko (hyperlipidemia).
• ʻO ka pehu (mumū) a kūkulu i ka momona i ke akepaʻa i ka poʻe inu inu liʻiliʻi a ʻaole paha i ka waiʻona (nonalcoholic steatohepatitis a i ʻole NASH).
• ʻO ka pehu (pehu) a me nā ʻeha ma loko o ka waha (mucositis oral).
• Hoʻopilikia ʻia e ka radiation therapy.
• Hoʻololi i nā bacteria maikaʻi i hoʻopau ʻia e ka diarrhea.
• Nā pilikia ʻōpū.
• ʻUshpala.
• Nā kūlana ʻē aʻe.

Pono nā hōʻike hou aʻe e helu i ka bifidobacteria no kēia mau hoʻohana.

Noho ka nui o nā bacteria a me nā meaola ʻē i loko o ko mākou kino. Hiki i nā huaola "launa" e like me bifidobacteria ke kōkua iā mākou e wāwahi i ka meaʻai, komo i nā meaola, a me ke kaua aku i nā meaola "ʻoluʻolu ʻole" i kumu ʻia nā maʻi e like me ka diarrhea

Ke lawe ʻia e ka waha: ʻO Bifidobacteria nā LIKELY SAFE no nā mākua olakino ke lawe ʻia e ka waha kūpono. I kekahi poʻe, hoʻonāukiuki paha ka mālama ʻana me ka bifidobacteria i ka ʻōpū a me ka ʻōpū, e loaʻa ai ka maʻi diarrhea, bloating and gas.

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hāpai a me ka hānai umauma: ʻO kahi kānana kikoʻī o bifidobacteria, Bifidobacterium bifidum, ʻo ia SAFE MAU PONO ke lawe ʻia e ka waha kūpono no 6 mau pule i ka wā e hāpai ana. ʻAʻole lawa ka ʻike pono e pili ana i ka palekana o ka lawe ʻana i nā ʻano bifidobacteria ʻē aʻe inā ʻoe hāpai a hānai umauma paha. Noho ma ka ʻaoʻao palekana a pale i ka hoʻohana.

Nā keiki: ʻO Bifidobacteria nā LIKELY SAFE no nā keiki heathy ke lawe ʻia e ka waha kūpono. ʻOiai ua loaʻa nā hihia o ka maʻi koko me ka bifidobacteria i nā pēpē maʻi nui, kākaʻikahi kēia mau hihia.

ʻŌnaehana pale nawaliwali: Aia kekahi hopohopo e ulu maikaʻi paha nā "probiotics" i ka poʻe me ka ʻōnaehana pale nawaliwali a kumu i nā maʻi. ʻOiai ʻaʻole kūlike kēia me bifidobacteria, aia kekahi mau hihia e pili ana i nā ʻano probiotic e like me Lactobacillus. Inā loaʻa iā ʻoe kahi ʻōnaehana nāwaliwali nāwaliwali (e laʻa me, loaʻa iā ʻoe ka maʻi HIV / AIDS a i ʻole ke mālama ʻia ʻana i ka maʻi ʻaʻai), e hōʻoia me kāu kauka olakino ma mua o ka hoʻohana ʻana i ka bifidobacteria.

Ka poloka ma nā ʻōpū: Ua hōʻike ʻia ʻelua mau maʻi o ke koko no nā pēpē i hāʻawi ʻia i nā probiotics bifidobacteria. I nā kūlana ʻelua, ua ʻoki ʻia ka ʻōpū ma ʻōpū. Manaʻo ʻia ʻo nā maʻi koko ke kumu o ka paʻa ʻana o ka ʻōpū ma muli o nā ʻōpū o ka ʻōpū, i ʻae ai i ka bifidobacteria e hele i ke kahe o ke koko. I kekahi hihia, ʻo ka lawe ʻana i ka bifidobacteria ma hope o ka hoʻoponopono ʻia ʻana o ka ʻōpū i kumu ʻole ʻia ai ka maʻi koko ʻē aʻe. No laila ʻaʻole hopohopo ka pilikia o nā maʻi koko no ka hapanui o nā pēpē e lawe ana i ka bifidobacteria. Akā pono e hoʻohana akahele ʻia nā bifidobacteria a pale ʻia paha i nā pēpē me nā ʻōpū a me nā wahi ʻōpū.

Kānāwai

E akahele me kēia hui ʻana.

Nā lāʻau Antibiotic

Hoʻohana ʻia nā lāʻau antibiotic e hoʻemi i nā koʻohune ʻino i ke kino. Hiki i nā Antibiotics ke hoʻemi i ka bacteria aloha i loko o ke kino. ʻO Bifidobacteria kahi ʻano o nā koʻohuna aloha. ʻO ka lawe ʻana i nā antibiotic me ka bifidobacteria e hōʻemi paha i ka maikaʻi o ka bifidobacteria. I mea e hōʻalo ai i kēia pilina, lawe i nā huahana bifidobacteria ma kahi o ʻelua mau hola ma mua a ma hope paha o nā lāʻau antibiotic.

ʻAʻole ʻike ʻia nā launa pū me nā mea kanu a me nā mea hoʻopili.

ʻAʻole ʻike ʻia nā launa me nā meaʻai.

Ua aʻo ʻia nā mahele aʻe i ka noiʻi ʻepekema:

NA MAKAHIKI

E ka waha:

• No ka paʻa paʻa: 100 miliona a 20 biliona mau kikowaena kolone o bifidobacteria i hoʻohana ʻia i kēlā me kēia lā. I ka hapanui o nā hihia, lawe ʻia nā bifidobacteria i kēlā me kēia lā no 1-4 mau pule. I kekahi mau hihia i lawe ʻia i 5-60 biliona mau kikowaena kolamu o bifidobacteria me lactobacillus i kēlā me kēia lā no 1 pule a 1 mahina.
• No kahi maʻi lōʻihi lōʻihi o nā ʻōpū nui e hōʻeha i ka ʻeha o ka ʻōpū (irritable bowel syndrome or IBS): No ka hoʻomaikaʻi ʻana i ka ʻōpū a me nā ʻōpū o ka ʻōpū, ua hoʻohana ʻia he 100 miliona a 1 biliona mau kolone o nā bifidobacteria i kēlā me kēia lā no 4-8 mau pule. Eia kekahi, ua hoʻohana ʻia he 5 biliona kolona o nā bifidobacteria a me ka lactobacillus a me ka streptococcus i ʻelua mau lā no 4 mau pule. No ka hoʻomaikaʻi ʻana i ke kaumaha a me ka hopohopo i ka poʻe me IBS, ua hoʻohana ʻia he 10 biliona kolona o nā bifidobacteria i hoʻokahi manawa i kēlā me kēia lā no 6 mau pule.
• No ka maʻi o nā alaloa: Ua hoʻohana ʻia he 3 biliona kolona o nā bifidobacteria i kēlā me kēia lā no 6 mau pule.
• No ka complication ma hope oʻoki kino no ulcerative colitis (pouchitis): hāʻawi ʻia kahi mahele o a i 3 trillion mau kolone-e hoʻokumu ana i nā ʻāpana o bifodobacteria a me ka lactobacillus a me ka streptococcus i kēlā me kēia lā no nā mahina he 12.
• No kahi maʻi maʻi digestive e hiki ai i nā ulcer (Helicobacter pylori a i ʻole H. pylori): 5 biliona hui-hoʻokumu o nā bifidobacteria me ka lactobacillus i kēlā me kēia lā no 1 pule i ka wā o H. pylori lapaʻau me hoʻokahi pule ma hope ua hoʻohana ʻia.
• No kahi ʻano maʻi maʻi ʻōpū (ulcerative colitis): No ka hoʻonui ʻana i ke kala ʻana, ua hoʻohana ʻia he 3 a ʻelua mau manawa i kēlā me kēia lā no 900 biliona o nā kolona e hana ana i nā kolone o lactobacillus a me bifidobacteria a me streptococcus.

KEIKI

E ka waha:

• No ka paʻa paʻa: Ua hoʻohana ʻia nā ʻāpana koloni o 1-100 biliona o bifidobacteria i kēlā me kēia lā no 4 mau pule i nā keiki o 3-16 mau makahiki.
• ʻO kahi maʻi lōʻihi lōʻihi o nā ʻōpū nui e hōʻeha i ka ʻeha o ka ʻōpū (irritable bowel syndrome or IBS): Ua hoʻohana ʻia he 10 mau biliona kolona o nā bifidobacteria i kēlā me kēia lā no 4 mau pule.
• No ka maʻi o nā alaloa: Ua hoʻohana ʻelua mau biliona biliona o nā kolone o nā bifidobacteria me ka lactobacillus i ʻelua mau lā i nā keiki i piha i ka makahiki 3-13.
• No ka maʻi diarrhea i hoʻokumu ʻia e rotavirus: ʻO Bifidobacteria, me a i ʻole me streptococcus, ua hoʻohana ʻia i nā keiki a hiki i ka 3 mau makahiki. Eia kekahi, ua hoʻohana ʻia ka bifidobacteria a me ka lactobacillus i ʻelua mau lā no 3 mau lā.
• No kahi ʻano maʻi maʻi ʻōpū (ulcerative colitis): Aia a i 1,8 trillion mau kolone-e hoʻokumu ana i nā bifidobacteria me ka lactobacillus a me ka streptococcus i hoʻohana ʻia i kēlā me kēia lā a hiki i 1 mau makahiki i nā keiki 1-16 mau makahiki.

B. Bifidum, B. Breve, B. Infantis, B. lactis, B. Longum, Bifido, Bifido Bacterium Longum, Bifidobacterias, Bifidobactérie, Bifidobactéries, Bifidobacterium, Bifidobacterium adolescentis; Bifidobacterium animalis, Bifidobacterium bifidum; Bifidobacterium breve; Bifidobacterium infantis; Bifidobacterium lactis; Bifidobacterium longum, Bifidum, Bifidus, Bifidus Brevis, Bifidus Infantis, Bifidus Longum, Bifidobacteria Bifidus, Lactobacillus Bifidus, L. Bifidus, Probiotic, Probiotique.

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.

1. Athalye-Jape G, Minaee N, Nathan E, et al. Nā hopena i ka preterm liʻiliʻi me ka kūpono no nā pēpē hāpai ma hope o Bifidobacterium breve M-16 V supplementation. ʻO J Matern Fetal Neonatal Med. 2020; 33: 2209-2215. Nānā kiʻi ʻole.
2. Wu G, Chen X, Cui N, et al. Ka hopena Preventive o ka Bifidobacterium supplementation ma neonatal cholestasis i nā preterm neonates me ka haʻahaʻa hānau kaumaha. Hana Hana Gastroenterol. 2020; 2020: 4625315. Nānā kiʻi ʻole.
3. Xiao J, Katsumata N, Bernier F, et al. ʻO ka Probiotic bifidobacterium breve i ka hoʻomaikaʻi ʻana i nā hana noʻonoʻo o nā mākua me ka hōʻino ʻia o ka naʻau haʻahaʻa. He hoʻokolohua kaulike ʻole, makapō makapō, kahi hoʻokolokolo. ʻO J Alzheimers Dis. 2020; 77: 139-147. Nānā kiʻi ʻole.
4. Lin CL, Hsu YJ, Ho HH, et al. Bifidobacterium longum subsp. loiloi OLP-01 longum i ka hoʻomaʻamaʻa ʻana i ka hoʻomaʻamaʻa holo ʻana e hoʻomaikaʻi i ka hana hoʻoikaika kino ma waena a me nā poʻe holo lōʻihi: kahi hoʻokolokolo hoʻokele makapō makapō. Nutrients. 2020; 12: 1972. Nānā kiʻi ʻole.
5. Lewis ED, Antony JM, Crowley DC, et al. Ka maikaʻi o Lactobacillus paracasei HA-196 a me Bifidobacterium longum R0175 i ka hoʻoliʻiliʻi ʻana i nā ʻōuli o ka huhū o ka bowel syndrome (IBS): kahi noiʻi i hoʻonohonoho ʻia me ka placebo. Nutrients. 2020; 12: 1159. Nānā kiʻi ʻole.
6. Michael DR, Jack AA, Masetti G, et al. Hōʻike kahi loiloi i hoʻopaʻa ʻia randomized supplementation of overweight a obese mākua me ka lactobacilli a me ka bifidobacteria e hoʻēmi ai i ke kino a hoʻomaikaʻi i ka maikaʻi. Luna Rep. 2020; 10: 4183. Nānā kiʻi ʻole.
7. Czajeczny D, Kabzi & nacute; ska K, Wójciak RW. Kōkua paha ka supplementation probiotic i ka pohō kaumaha? ʻO kahi noiʻi randomized, blind-blind, placebo-kāohi ʻia me Bifidobacterium lactis BS01 a me Lactobacillus acidophilus LA02 hoʻohui. Eʻai i ka kaumaha kaumaha. 2020. E nānā abstract.
8. ʻO Jiao X, Fu MD, Wang YY, Xue J, Zhang Y. Bifidobacterium a me Lactobacillus no ka pale ʻana i ka enterrotolitis necrotizing i loko o nā pēpē preterm haʻahaʻa haʻahaʻa: kahi loiloi ʻōnaehana a me ka meta-analysis. Honua J Pediatr. 2020; 16: 135-142. Nānā kiʻi ʻole.
9. Sadeghi-Bojd S, Naghshizadian R, Mazaheri M, Ghane Sharbaf F, Assadi F. Ka hopena o nā probiotic prophylaxis ma hope o ka maʻi febrile urinary tract i loaʻa i nā keiki me nā wahi urinary maʻamau. ʻO J Pediatric Infect Dis Soc. 2020; 9: 305-310. Nānā kiʻi ʻole.
10. Butler CC, Lau M, Gillespie D, et al. Ka hopena o ka hoʻohana probiotic ma ka hoʻoponopono antibiotic ma waena o nā poʻe noho home mālama: kahi hoʻokolokolo hoʻokolohua kaulike. JAMA. 2020; 324: 47-56. Nānā kiʻi ʻole.
11. Zhu XL, Tang XG, Qu F, Zheng Y, Zhang WH, Diao YQ. Hiki i ka Bifidobacterium ke kōkua i ka pale ʻana i ka enterrotrotrot nekrotizing i nā pēpē mua: He loiloi ʻōnaehana a me nā meta-analysis. ʻO Int J Surg. 2019; 61: 17-25. Nānā kiʻi ʻole.
12. Wang G, Feng D. Therapeutic hopena o Saccharomyces boulardii i hui pū ʻia me Bifidobacterium a me nā hana pale paʻa paʻa pūnaewele i nā keiki me ka nui o ka diarrhea. ʻO Exp Ther Med. 2019; 18: 2653-2659. Nānā kiʻi ʻole.
13. Sharif A, Kashani HH, Nasri E, Soleimani Z, Sharif MR. Ke kuleana o Probiotics i ka mālama ʻana i ka Dysentery: kahi hoʻokolohua hoʻokolohua kaulua kaulua. Probiotics Antimicrob Pūnaewele. 2017; 9: 380-385. Nānā kiʻi ʻole.
14. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Palekana anei nā probiotics? ʻO Bifidobacterium bacteremia i kahi keiki me ka puʻuwai puʻuwai koʻikoʻi. ʻO Infez Med. 2019; 27: 175-178. Nānā kiʻi ʻole.
15. Manzhalii E, Virchenko O, Falalyeyeva T, Beregova T, Stremmel W. Pono pono o ka hoʻomākaukau probiotic no steatohepatitis non-alkohol: kahi hoʻokolohua pailaka. ʻO J Dig Dis. 2017; 18: 698-703. Nānā kiʻi ʻole.
16. Kobayashi Y, Kuhara T, Oki M, Xiao JZ. Nā hopena o Bifidobacterium breve A1 ma ka hana noʻonoʻo o nā mākua me nā hoʻopiʻi hoʻomanaʻo: kahi hoʻokolohua, makapō makapō, hoʻokolokolo ʻia me ka placebo. ʻO nā Microbes pono. 2019; 10: 511-520. Nānā kiʻi ʻole.
17. Jiang C, Wang H, Xia C, et al. Hoʻokolohua, pālua makapō, hoʻokolohua hoʻokolohua placebo o probiotics e hoʻoliʻiliʻi i ke koʻikoʻi o ka mucositis waha i hoʻoulu ʻia e chemoradiotherapy no nā mea maʻi me ka carcinoma nasopharyngeal. Kanesa. 2019; 125: 1081-1090. Nānā kiʻi ʻole.
18. Inoue T, Kobayashi Y, Mori N, et al. Ka hopena o ka hoʻohui bifidobacteria hoʻohui a me ka hoʻomaʻamaʻa kūʻē ʻana i ka hana noʻonoʻo, ke ʻano o ke kino a me nā ʻōpū o ke ʻōpū o nā ʻelemākule olakino olakino. Pōmaikaʻi i nā Microbes. 2018; 9: 843-853. Nānā kiʻi ʻole.
19. Dimidi E, Zdanaviciene A, Christodoulides S, et al. ʻO ka hoʻokolohua hoʻokolohua kaulike ʻia: Bifidobacterium lactis NCC2818 probiotic vs placebo, a me ka hopena o ka manawa transit, ʻōuli, a me ka microbiology ʻōpū i ka paʻa paʻa mau. ʻO Aliment Pharmacol Ther. 2019; 49: 251-264. Nānā kiʻi ʻole.
20. ʻO Caglar E. Nā hopena o Bifidobacterium bifidum i loaʻa ka yoghurt ma nā koʻohune plaque niho i nā keiki. ʻO J Clin Pediatr Dent. 2014; 38: 329-32. Nānā kiʻi ʻole.
21. Zhang J, Ma S, Wu S, Guo C, Long S, Tan H. Nā hopena o ka Probiotic Supplement i nā Wahine hāpai me ka Gestational Diabetes Mellitus: He ʻōnaehana ʻōnaehana a me ka Meta-ʻIkepili o nā hoʻokolohua kaulike kaulike ʻia. ʻO J Diabetes Res. 2019; 2019: 5364730. Nānā kiʻi ʻole.
22. Slykerman RF, Kang J, Van Zyl N, et al. ʻO ka hopena o ka probiotic supplementation ma ke ʻano o ke kamaliʻi, ka hana a me ke ʻano i kahi hoʻokolokolo i hoʻokolokolo ʻia me kahi placebo. ʻO Acta Paediatr. 2018; 107: 2172-2178. Nānā kiʻi ʻole.
23. Schmidt RM, Pilmann Laursen R, Bruun S, et al. ʻO nā Probiotics i ka wā kamaliʻi liʻiliʻi e hōʻemi i ka hanana o ka eczema: Pediatr Allergy Immunol. 2019; 30: 335-340. Nānā kiʻi ʻole.
24. Linn YH, Thu KK, Lanakila NHH. Ka hopena o nā Probiotics no ka pale ʻana i ka maʻi pākī i hoʻokomo ʻia i waena o nā mea maʻi maʻi maʻi cer servic: kahi Randomized Double-Blind Placebo-Controlled Study. Probiotics Antimicrob Pūnaewele. 2019; 11: 638-647. Nānā kiʻi ʻole.
25. Callaway LK, McIntyre HD, Barrett HL, et al. Nā Probiotics no ka Kāohi ʻana i ka Gestational Diabetes Mellitus i ka wahine kaumaha a me nā wahine nui nui: nā ʻike mai ka SPRING Double-Blind Randomized Controlled Trial. Mālama Diabetes. 2019; 42: 364-371. Nānā kiʻi ʻole.
26. ʻO Staudacher HM, Lomer MCE, Farquharson FM, et al. ʻO kahi papaʻai haʻahaʻa ma FODMAP e hoʻoliʻiliʻi i nā ʻōuli i nā mea maʻi me ka Irritable Bowel Syndrome a me kahi Probiotic e hoʻihoʻi i nā ʻano Bifidobacterium: kahi hoʻokolohua hoʻokolohua kaulike ʻole ʻia. Gastroenterology. 2017; 153: 936-947. Nānā kiʻi ʻole.
27. Matsuoka K, Uemura Y, Kanai T, et al. Ka hopena o ka Bifidobacterium breve Milk Fermented i ka mālama ʻana i ke kala ʻana o ka Ulcerative Colitis. ʻO Dig Dis Sci. 2018; 63: 1910-1919. Nānā kiʻi ʻole.
28. Liu J, Huang XE. Ka hopena o Bifidobacterium tetragenous hiki ke ola i nā papa bacteria no nā mea maʻi maʻi ʻaʻai me ka paʻa paʻa paʻa. ʻO Asian Pac J Ka maʻi ʻaʻai Prev. 2014; 15: 10241-4. Nānā kiʻi ʻole.
29. Lau AS, Yanagisawa N, Hor YY, et al. ʻO Bifidobacterium longum BB536 ka mea i hōʻemi i nā maʻi hanu o luna a hoʻololi i nā moʻolelo microbiota ʻōpū i nā keiki kula mua o Malaysia. Pōmaikaʻi i nā Microbes. 2018; 9: 61-70. Nānā kiʻi ʻole.
30. ʻO Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Nā hopena o ka 28-lā Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time a me nā ʻōpū o ka ʻōpū i nā mākua me ka constipation hana: He makapō makapō, hoʻomohala ʻia, kahi placebo-kāohi ʻia, a me kahi hoʻokolokolo. ʻO Microbes Gut. 2018; 9: 236-251. Nānā kiʻi ʻole.
31. Guardamagna O, Amaretti A, Puddu PE, et al. Hoʻohui Bifidobacteria: nā hopena ma nā hōʻike lipid plasma i nā keiki dislipidemic. Meaʻai kūpono. 2014; 30 (7-8): 831-6. Nānā kiʻi ʻole.
32. Badehnoosh B, Karamali M, Zarrati M, et al. ʻO nā hopena o ka probiotic supplementation ma biomarkers o ka mumū, ke kaumaha oxidative a me nā hopena hāpai i ka diabetes diabetes. ʻO J Matern Fetal Neonatal Med. 2018 Mei; 31: 1128-1136. Nānā kiʻi ʻole.
33. Dickerson F, Adamos M, Katsafanas E, et al. ʻO nā microorganism probiotic āpau e pale ai i ka rehospitalization i nā mea maʻi me ka mania koʻikoʻi: kahi hoʻāʻo ʻana i hoʻomalu ʻia. Hae Bipolar. 2018 Apr 25. Nānā i nā kahakaha.
34. Pinto GS, Cenci MS, Azevedo MS, Epifanio M, Jones MH. Ka hopena o ka yogurt i loaʻa iā Bifidobacterium animalis subsp. lactis DN-173010 probiotic ma ka pā niho a me ka lawai i nā mea maʻi orthodontic. Kale Res. 2014; 48: 63-8. Nānā kiʻi ʻole.
35. Zamani B, Golkar HR, Farshbaf S, et al. ʻO ka pane olakino a me ka metabolic i ka probiotic supplementation i nā mea maʻi me ka rheumatoid arthritis: kahi i hoʻokolohua ʻole ʻia, pālua makapō, hoʻokolokolo ʻia me ka placebo. Int J Rheum Dis 2016; 19: 869-79. Nānā kiʻi ʻole.
36. Pinto-Sanchez MI, Hall GB, Ghajar K, et al. ʻO Probiotic Bifidobacterium longum NCC3001 e hoʻoliʻiliʻi i nā helu kaumaha a hoʻololi i ka hana lolo: kahi aʻo pailaka i nā mea maʻi me ka maʻi hanu huhū. Gastroenterology 2017; 153: 448-459.e8. Nānā kiʻi ʻole.
37. Karamali M, Dadkhah F, Sadrkhanlou M, et al. Nā hopena o ka probiotic supplementation ma ka glycemic control a me nā lipid profiles i ka mimikō gestational: kahi randomized, double-blind, placebo-control trial. Diabetes Metab 2016; 42: 234-41. Nānā kiʻi ʻole.
38. ʻO Jäger R, Purpura M, Pōhaku JD, et al. Hoʻopiʻi ka Probiotic Streptococcus thermophilus FP4 a me Bifidobacterium brev BR03 supplementation i ka hana a me nā hoʻoliʻiliʻi laulā o ka neʻe ma hope o ka hoʻoikaika kino i nā mākala. Nutrients 2016; 8. pii: E642. Nānā kiʻi ʻole.
39. ʻO Whorwell PJ, Altringer L, Morel J, et al. Ka hopena o kahi probiotic Bifidobacterium infantis 35624 i hoʻopaʻa ʻia i nā wahine me ka maʻi huhū huhū. ʻO Am J Gastroenterol. 2006 Jul; 101: 1581-90. Nānā kiʻi ʻole.
40. Lau CS, Chamberlain RS. Kūpono nā Probiotics i ka pale ʻana iā Clostridium difficile-pili diarrhea: kahi ʻōnaehana loiloi a me nā meta-analysis. ʻO Int J Gen Med. 2016; 9: 27-37. Nānā kiʻi ʻole.
41. Stenman LK, Lehtinen MJ, Meland N, et al. ʻO Probiotic me ka ʻole a me ka ʻole o nā mana Fiber Kino Lā Nui, i hui pū ʻia me Serum Zonulin, i ka hoʻowalewale a me nā mākua Obese-Randomized Controlled Trial. EBioMedicine 2016; 13: 190-200. Nānā kiʻi ʻole.
42. Sato S, Uchida T, Kuwana S, et al. Hoʻokomo ʻia ka bacteriemia e Bifidobacterium breve i kahi keiki hānau hou me ka exacophy cloacal. ʻO Pediatr Int. 2016; 58: 1226-8. Nānā kiʻi ʻole.
43. Jayasimhan S, Yap NY, Roest Y, Rajandram R, Chin KF. Ka hopena o ka hoʻomākaukau o ka cell microbial i ka hoʻomaikaʻi ʻana i ka paʻa paʻa mau: kahi hoʻokolohua i hoʻokolohua ʻia, pālua makapō, kahi hoʻokolokolo. ʻO Clin Nutr 2013; 32: 928-34. Nānā kiʻi ʻole.
44. Han K, Wang J, Seo JG, Kim H. Ka hopena o nā probiotics pālua ʻia no ka maʻi huhū o ka bowel: kahi hoʻokolokolo hoʻokolohua makapō makapō. J Gastroenterol. 2017; 52: 432-443. Nānā kiʻi ʻole.
45. Chang HY, Chen JH, Chang JH, Lin HC, Lin CY, Peng CC. ʻO nā probiotics maha he mau probiotics ka mea i ʻoi aku ka maikaʻi o ka probiotics i ka pale ʻana i ka necrotizing enterocolitis a me ka make ʻana. PLoS Hoʻokahi. 2017; 12: e0171579. Nānā kiʻi ʻole.
46. ʻO Bastürk A, Artan R, Yilmaz A. Ka maikaʻi o nā lāʻau synbiotic, probiotic, a me prebiotic no ka maʻi huhū i loko o nā keiki. ʻO Turk J Gastroenterol 2016; 27: 439-43. Nānā kiʻi ʻole.
47. Blaabjerg S, Artzi DM, Aabenhus R. Probiotics no ka Prevent o Antibiotic-Associated Diarrhea i nā mea maʻi o waho-A Review Systematic a me Meta-Analysis. Nā Antibiotics (Basel). 2017; 6. Nānā kiʻi ʻole.
48. Al Faleh K, Anabree J. Probiotics no ka pale ʻana i ka enterrotrotitis necrotizing i nā pēpē preterm. ʻO Cochrane Database Syst Rev. 2014;: CD005496. Nānā kiʻi ʻole.
49. ʻO Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K. Ka hopena o nā probiotics i ka paʻa paʻa ʻana i nā mākua: kahi loiloi ʻōnaehana a me nā meta-analysis o nā hoʻokolohua hoʻokolohua kaulike ʻole ʻia. ʻO Am J Clin Nutr. 2014; 100: 1075-84. Nānā kiʻi ʻole.
50. Wildt S, Nordgaard I, Hansen U, Brockmann E, Rumessen JJ. ʻO kahi hoʻokolohua placebo-kāohi lua ʻia me Lactobacillus acidophilus La-5 a me Bifidobacterium animalis subsp. lactis BB-12 no ka mālama ʻana i ke kala ʻana i ka colitis ulcerative. ʻO J Crohns Colitis 2011; 5: 115-21. Nānā kiʻi ʻole.
51. ʻO Shen J, Zuo ZX, Mao AP. Ka hopena o nā probiotics ma ka hoʻoulu ʻana i ke kala ʻana a me ka mālama ʻana i ka hoʻōla ma ka ulcerative colitis, ka maʻi o Crohn, a me ka pouchitis: meta-analysis o nā hoʻokolohua hoʻokolohua kaulike ʻia. ʻO Inflamm Bowel Dis. 2014; 20: 21-35. Nānā kiʻi ʻole.
52. Park MS, Kwon B, Ku S, Ji GE4. Ka hopena o Bifidobacterium longum BORI a me Lactobacillus acidophilus AD031 Probiotic lapaʻau i nā pēpē me ka maʻi Rotavirus. Nutrients. 2017; 9. pii: E887. Nānā kiʻi ʻole.
53. ʻO Søndergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R. Nā hopena o ka waiū hānai probiotic ma luna o nā ʻōuli a me nā ʻōpū o ke kōpū i nā mea maʻi me ka maʻi hanu huhū: kahi randomized, placebo-control trial. Scand J Gastroenterol 2011; 46: 663-72. Nānā kiʻi ʻole.
54. Simrén M, Ohman L, Olsson J, et al. ʻO ka hoʻāʻo hoʻokolohua: nā hopena o ka waiū hū i piha i ʻekolu mau koʻohune probiotic i nā mea maʻi me ka maʻi hanu huhū - kahi papa, makapō makapō, a hoʻopaʻa ʻia i aʻo ʻia Aliment Pharmacol Ther 2010; 31: 218-27. Nānā kiʻi ʻole.
55. ʻO Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. ʻO nā Probiotics no ka pale ʻana i ka maʻi pākīpī pediatric-pili diarrhea. ʻO Cochrane Database Syst Rev. 2015;: CD004827. Nānā kiʻi ʻole.
56. O'Callaghan A, van Sinderen D. Bifidobacteria a me kā lākou kuleana ma ke ʻano he lālā o ka Human Gut Microbiota. ʻO Microbiol i mua. 2016 Jun 15; 7: 925. Nānā kiʻi ʻole.
57. ʻO Olivares M, Castillejo G, Varea V, Sanz Y.Pālua makapō, hoʻokolohua, hoʻokolohua hoʻokolohua hoʻokolohua hoʻokolohua hoʻokolokolo e loiloi i nā hopena o Bifidobacterium longum CECT 7347 i nā keiki me ka maʻi celiac hou i hōʻike ʻia. ʻO Br J Nutr. 2014 Jul 14; 112: 30-40. Nānā kiʻi ʻole.
58. Hojsak I, Tokic Pivac V, Mocic Pavic A, Pasini AM, Kolacek S. Bifidobacterium animalis subsp. ʻAʻole hiki i ka lactis ke pale aku i nā maʻi maʻamau i nā keiki i hōʻola ʻia i ka hale maʻi: kahi loiloi ʻole, pālua makapō, kahi hoʻomalu placebo. ʻO Am J Clin Nutr. 2015 Malaki; 101: 680-4. Nānā kiʻi ʻole.
59. Eskesen D, Jespersen L, Michelsen B, Whorwell PJ, Müller-Lissner S, Morberg CM. Ka hopena o ka probiotic kānana Bifidobacterium animalis subsp. lactis, BB-12®, ma ke alapine defecation i nā kumuhana olakino me ke alapine defecation haʻahaʻa a me ka hōʻoluʻolu o ka ʻōpū: kahi randomized, double-blind, placebo-control, parallel-group trial. ʻO Br J Nutr. 2015 Nov 28; 114: 1638-46. Nānā kiʻi ʻole.
60. Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR; ʻO Probiotics i ka Preterm pēpē hoʻopaʻa haʻawina hui pū. ʻO Bifidobacterium breve BBG-001 i nā pēpē mua loa: kahi hoʻokolohua i hoʻonohonoho ʻia i ka pae 3 i hoʻokolokolo ʻia. Lancet. 2016 Pepelu 13; 387: 649-60. Nānā kiʻi ʻole.
61. Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, Dhar A, Brown H, Foden A, Gravenor MB, Mack D. Lactobacilli a me bifidobacteria i ka pale ʻana i ka maʻi diarrhea e pili ana i nā antibiotic a me Clostridium difficile diarrhea i ka wā kahiko. nā mea komo maʻi (PLACIDE): kahi hoʻokolohua kaulike ʻole, pālua makapō, kahi placebo-kāohi ʻia, hoʻokolokolo multicentre. Lancet. 2013 ʻOkakopa 12; 382: 1249-57. Nānā kiʻi ʻole.
62. Roberfroid MB. Nā Prebiotics a me nā probiotics: he meaʻai kūpono paha ia? ʻO Am J Clin Nutr. 2000; 71 (6 Hōʻawi): 1682S-7S; kūkā 1688S-90S. Nānā kiʻi ʻole.
63. Wang YH, Huang Y. Ka hopena o Lactobacillus acidophilus a me Bifidobacterium bifidum supplementation i ka standard triple therapy ma Helicobacter pylori eradication a me nā hoʻololi ikaika i nā flora ʻōpū. ʻO World J Microbiol Biotechnol. 2014; 30: 847-53. Nānā kiʻi ʻole.
64. ʻO Wang ZH, ʻo Gao QY, ʻo Fang JY. ʻO ka Meta-analysis o ka pono a me ka palekana o Lactobacillus-piha a me Bifidobacterium-i loko o kahi hoʻomākaukau probiotic i loko Helicobacter pylori eradication therapy. ʻO J Clin Gastroenterol. 2013; 47: 25-32. Nānā kiʻi ʻole.
65. ʻO Videlock EJ, ʻo Cremonini F. Meta-analysis: probiotics i ka maʻi diarrhea-pili diarrhea. ʻO Aliment Pharmacol Ther. 2012; 35: 1355-69. Nānā kiʻi ʻole.
66. ʻO Tomasz B, Zoran S, Jaroslaw W, Ryszard M, Marcin G, Robert B, Piotr K, Lukasz K, Jacek P, Piotr G, Przemyslaw P, ʻo Michal D. ʻO ka hoʻohana lōʻihi o nā probiotics Lactobacillus a me Bifidobacterium kahi hopena prophylactic i ka hanana a me ke koʻikoʻi o ka pouchitis: kahi noiʻi prospective prospective. ʻO Biomed Res Int. 2014; 2014: 208064. Nānā kiʻi ʻole.
67. Shavakhi A, Tabesh E, Yaghoutkar A, Hashemi H, Tabesh F, Khodadoostan M, Minakari M, Shavakhi S, Gholamrezaei A. Nā hopena o ka multistrain probiotic compound ma ka bismuth-i loaʻa i ka quadruple therapy no Helicobacter pylori maʻi: a randomized placebo-control control -hoʻopaʻa haʻawina makapō. Helicobacter. 2013; 18: 280-4. Nānā kiʻi ʻole.
68. Rerksuppaphol S, Rerksuppaphol L. Hoʻoholo hoʻokolohua ʻia o nā probiotics e hoʻemi i ke anuanu maʻamau i nā keiki kula. ʻO Pediatr Int. 2012; 54: 682-7. Nānā kiʻi ʻole.
69. ʻO Rautava S, Kainonen E, Salminen S, Isolauri E. Hoʻohui probiotic makuahine i ka wā hāpai a me ka hānai ʻana i ka umauma hoʻemi i ka makaʻu o ka eczema i loko o ke pēpē. ʻO J Allergy Clin Immunol. 2012; 130: 1355-60. Nānā kiʻi ʻole.
70. Langkamp-Henken B, Rowe CC, Ford AL, Christman MC, N steal C Jr, Khouri L, Specht GJ, Girard SA, Spaiser SJ, Dahl WJ. Nā hualoaʻa o Bifidobacterium bifidum R0071 i kahi mahele nui o nā lā olakino a me ka hapa haʻahaʻa o nā haumāna i aʻo koʻikoʻi i ka hōʻike ʻana i kahi lā o ke anuanu / flu: kahi randomized, blind-blind, placebo-control study. ʻO Br J Nutr. 2015 14; 113: 426-34. Nānā kiʻi ʻole.
71. ʻO Gore C, Custovic A, Tannock GW, Munro K, Kerry G, Johnson K, Peterson C, Morris J, Chaloner C, Murray CS, Woodcock A. Hoʻomaʻamaʻa a me nā hopena pale lua o nā probiotics Lactobacillus paracasei a i ʻole Bifidobacterium lactis i ka eczema pēpē mua. : hoʻokolohua hoʻokolohua kaulike ʻia me ka ukali a hiki i nā makahiki 3. ʻO Clin Exp Allergy 2012; 42: 112-22. Nānā kiʻi ʻole.
72. Fernández-Carrocera LA, Solis-Herrera A, Cabanillas-Ayón M, Gallardo-Sarmiento RB, García-Pérez CS, Montaño-Rodríguez R, Echániz-Aviles MO. Pālua makapō, hoʻokolohua hoʻokolohua hoʻokolohua e loiloi i ka pono o nā probiotics i nā keiki hānau hou e kaupaona ana ma lalo o 1500 g i ka pale ʻana i ka enterocolitis necrotising. Arch Dis Child Fetal Neonatal Ed 2013; 98: F5-9. Nānā kiʻi ʻole.
73. Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. ʻO ka mālama wā lōʻihi me nā probiotics i nā mea maʻi mālama mua me ka maʻi hanu huhū - kahi hoʻokolohua hoʻokolohua, makapō makapō, placebo kāohi ʻia. Scand J Gastroenterol 2013; 48: 1127-35. Nānā kiʻi ʻole.
74. Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor MB, Garaiova I, Plummer SF, Wang D, Morgan G. Probiotics i ka pale ʻana i ka eczema: kahi hoʻokolohua hoʻokolohua kaulike ʻole ʻia. Arch Dis Child 2014; 99: 1014-9. Nānā kiʻi ʻole.
75. ʻO Das RR.Singh M, Shafiq N. Probiotics i ka mālama ʻana i ka Rhinitis Allergic. Ka Nūpepa Hui Alakaʻi Honua o ka Honua 2010; 3: 239-244.
76. ʻO Seki M, Igarashi T Fukuda Y Simamura S Kaswashima T Ogasa K. Ka hopena o Bifidobacterium i hana ʻia i ka waiū ma ka "maʻamau" ma waena o kahi hui kahiko. Nutr Foodstuff 1978; 31: 379-387.
77. Kageyama T, Nakano Y Tomoda T. Haʻawina hoʻohālikelike e pili ana i ka hoʻoponopono waha o kekahi mau hoʻomākaukau Bifidobacterium. Lapaʻau a me Biology (Iapana) 1987; 115: 65-68.
78. Kageyama T, Tomoda T Nakano Y. Ka hopena o ka Bifidobacterium Administration i nā mea maʻi me Leukemia. ʻO Bifidobacteria Microflora. 1984; 3: 29-33.
79. Ballongue J, Grill J Baratte-Euloge P. Action sur la flore intestinale de laits fermentés au Bifidobacterium. ʻO Lait 1993; 73: 249-256.
80. Ogata T, Kingaku M Yaeshima T Teraguchi S Fukuwatari Y Ishibashi N Hayasawa H Fujisawa T Lino H. Ka hopena o ka Bifidobacterium longum BB536 yogurt lawelawe ʻana ma ka ʻōpū o nā mākua olakino olakino. ʻO Microb Ecol Health Dis 1999; 11: 41-46.
81. ʻO Tomoda T, Nakano Y Kageyama T. Hoʻololi i nā Pūʻulu liʻiliʻi o Florest Intestinal Flora i ka wā o ka mālama ʻana i nā lāʻau Anticancer a i ʻole Immunosuppressive Drugs. Lapaʻau a me Biology (Iapana) 1981; 103: 45-49.
82. ʻO Tomoda T, Nakano Y Kageyama T. Intestinal Candida Overgrowth a me ka maʻi Candida i nā maʻi me ka Leukemia: Ka hopena o ka Bifidobacterium Administration. Bifidobacteria Microflora 1988; 7: 71-74.
83. Araya-Kojima Tomoko, Yaeshima Tomoko Ishibashi Norio Shimamura Seiichi Hayasawa Hirotoshi. Nā hopena kūpale o Bifidobacterium longum BB536 ma ka Bakteric Intestinal Harmful. Bifidobacteria Microflora 1995; 14: 59-66.
84. Namba K, Yaeshima T Ishibashi N Hayasawa H a me Yamazaki Shoji. Nā hopena kaohi o Bifidobacterium longum ma Enterohemorrhagic Escherichia coli O157: H7. Bioscience Microflora 2003; 22: 85-91.
85. ʻO Igarashi M, Iiyama Y Kato R Tomita M Asami N Ezawa I. Ka hopena o Bifidobacterium longum a me ka lactulose i ka ikaika o ka iwi i nā helu hoʻohālikelike osteoporosis ovariectomized. Bifidus 1994; 7: 139-147.
86. Yaeshima T, Takahashi S Ota S Nakagawa K Ishibashi N Hiramatsu A Ohashi T Hayasawa H Iino H. Ka hopena o ka yogurt momona i loaʻa iā Bifidobacterium longum BB536 ma ke ʻano pinepine pinepine a me nā ʻano fecal o nā mākua olakino: kahi hoʻohālikelike me ka yogurt maʻamau momona. Kenko Eiyo Shokuhin Kenkyu 1998; 1 (3/4): 29-34.
87. Yaeshima T, Takahashi S Matsumoto N Ishibashi N Hayasawa H Lino H. Ka hopena o ka yogurt i loaʻa iā Bifidobacterium longum BB536 ma ke ʻano o ka ʻōpū, nā ʻano fecal a me ka pinepine defecation: kahi hoʻohālikelike me ka yogurt maʻamau. ʻO Biosci Microflora 1997; 16: 73-77.
88. Xiao J, Kondol S Odamaki T Miyaji K Yaeshima T Iwatsuki K Togashi H Benno Y. Ka hopena o ka yogurt i loaʻa iā Bifidobacterium longum BB 536 ma ke alapine defecation a me nā ʻano fecal o nā mākua olakino: He papalua makapō ma luna o ka noiʻi. Ka Nupepa Kepanī o Lactic Acid Bacteria 2007; 18: 31-36.
89. Yaeshima T, Takahashi S Ogura A Konno T Iwatsuki K Ishibashi N Hayasawa H. Ka hopena o ka waiū non-fermented e loaʻa ana iā Bifidobacterium longum BB536 ma ke ʻano pinepine pinepine a me nā hiʻohiʻona fecal i nā olakino olakino. Ka Nūpepa o Nutr Food 2001; 4: 1-6.
90. Ogata T, Nakamura T Anjitsu K Yaeshima T Takahashi S Fukuwatari Y Ishibashi N Hayasawa H Fujisawa T Iino H. Ka hopena o ka Bifidobacterium longum BB536 lawelawe ma ka ʻōpū o ka ʻōpū, ka pinepine o ka defecation a me nā ʻano fecal o nā mea manawaleʻa kanaka. Biosci Microflora 1997; 16: 53-58.
91. Iwabuchi N, Hiruta N Kanetada S Yaeshima T Iwatsuki K Yasui H. Nā hopena o ka Intranasal Administration o Bifidobacterium longum BB536 ma ka Mucosal Immune System i ka Respiratory Tract a me ka Influenza Virus Infection i nāʻiole. Milk Science 2009; 38: 129-133.
92. ʻO Sekine I, Yoshiwara S Homma N Takanori H Tonosuka S. Nā hopena o ka waiū i loko o Bifidobacterium ma ka hopena chemiluminescence o nā leukocytes peripheral a me ka nui o ke kino o nā kolamu koko ʻula - kahi kuleana o Bifidobacterium i ka hoʻoulu ʻana o macrophages. Nā Haumāna (Iapana) 1985; 14: 691-695.
93. Singh, J., Rivenson, A., Tomita, M., Shimamura, S., Ishibashi, N., a me Reddy, BS Bifidobacterium longum, kahi lactic acid-e hana ana i ka bacteria bacteri e kāpae i ka maʻi ʻaʻai kolone a hoʻololi i nā biomarkers waena o ka car carogenogenesis kolona. . Carcinogenesis 1997; 18: 833-841. Nānā kiʻi ʻole.
94. ʻO Reddy, B. S. a me Rivenson, A. He hopena hoʻokiʻekiʻa o Bifidobacterium longum ma ke kolona, ​​mammary, a me ka carcinogenesis ate i hoʻopili ʻia e 2-amino-3-methylimidazo [4,5-f] quinoline, kahi meaʻai meaʻai. ʻO Res. 9-1-1993; 53: 3914-3918. Nānā kiʻi ʻole.
95. Yamazaki, S., Machii, K., Tsuyuki, S., Momose, H., Kawashima, T., a me Ueda, K. Nā pane Immunological i ka monoassociated Bifidobacterium longum a me kā lākou pili i ka pale ʻana i ka hoʻouka kaua bacteria. Immunology 1985; 56: 43-50. Nānā kiʻi ʻole.
96. Kondo, J., Xiao, J. Z., Shirahata, A., Baba, M., Abe, A., Ogawa, K., a me Shimoda, T. Nā hopena o Bifidobacterium longum BB536 ma ka hoʻohaunaele ʻana i nā mea maʻi ʻelemakule e loaʻa ana ka ʻai komo. World J Gastroenterol 4-14-2013; 19: 2162-2170. Nānā kiʻi ʻole.
97. Akatsu, H., Iwabuchi, N., Xiao, JZ, Matsuyama, Z., Kurihara, R., Okuda, K., Yamamoto, T., a me Maruyama, M. Nā hopena olakino o Probiotic Bifidobacterium longum BB536 ma Immune Function a me ʻO ka Microbiota Intestinal i nā mea maʻi kūpuna e loaʻa ana ka hānai Tube Enteral. ʻO JPEN J Parenter Enteral Nutr 11-27-2012; Nānā kiʻi ʻole.
98. Odamaki, T., Sugahara, H., Yonezawa, S., Yaeshima, T., Iwatsuki, K., Tanabe, S., Tominaga, T., Togashi, H., Benno, Y., a me Xiao, JZ Effect o ka waha waha o ka yogurt i loaʻa iā Bifidobacterium longum BB536 ma nā helu kelepona o enterotoxigenic Bacteroides fragilis i ka microbiota. Anaerobe. 2012; 18: 14-18. Nānā kiʻi ʻole.
99. Iwabuchi, N., Xiao, J. Z., Yaeshima, T., a me Iwatsuki, K. ʻO ka lawelawe waha ʻana o Bifidobacterium longum ameliorates maʻi maʻi virus influenza i nāʻiole. Biol.Pharm.Bull. 2011; 34: 1352-1355. Nānā kiʻi ʻole.
100. Simakachorn, N., Bibiloni, R., Yimyaem, P., Tongpenyai, Y., Varavithaya, W., Grathwohl, D., Reuteler, G., Maire, JC, Blum, S., Steenhout, P., Benyacoub , J., a me Schiffrin, EJ Tolerance, palekana, a me ka hopena o ka microbiota faecal o kahi papa hana komo i hoʻohui ʻia me nā probiotics ma mua a me nā probiotics i nā keiki maʻi nui. J Pediatr.Gastroenterol.Nutr. 2011; 53: 174-181. Nānā kiʻi ʻole.
101. Hascoet, J. M., Hubert, C., Rochat, F., Legagneur, H., Gaga, S., Emady-Azar, S., a me Steenhout, P. G. Ka hopena o ka hoʻopili ʻana i ka hoʻomohala ʻana i ka microbiota kōpū pēpē. J Pediatr.Gastroenterol.Nutr. 2011; 52: 756-762. Nānā kiʻi ʻole.
102. Firmansyah, A., Dwipoerwantoro, P. G., Kadim, M., Alatas, S., Conus, N., Lestarina, L., Bouisset, F., a me Steenhout, P. Hoʻonui i ka ulu ʻana o nā kamaliʻi i hānai i kahi waiū i loaʻa nā synbiotics. ʻO Asia Pac.J Clin.Nutr. 2011; 20: 69-76. Nānā kiʻi ʻole.
103. Tang, M. L., Lahtinen, S. J., a me Boyle, R. J. Probiotics a me nā prebiotics: nā hopena maʻi i ka maʻi maʻi. ʻO Curr.Opin.Pediatr. 2010; 22: 626-634. Nānā kiʻi ʻole.
104. Namba, K., Hatano, M., Yaeshima, T., Takase, M., a me Suzuki, K. Nā hopena o ka Bifidobacterium longum BB536 lawelawe ʻana i ka maʻi influenza, titer antibody antibody titer, a me ka pale waena waena o ka poʻe ʻelemakule. ʻO Biosci.Biotechnol.Biochem. 2010; 74: 939-945. Nānā kiʻi ʻole.
105. Gianotti, L., Morelli, L., Galbiati, F., Rocchetti, S., Coppola, S., Beneduce, A., Gilardini, C., Zonenschain, D., Nespoli, A., a me Braga, M. ʻO ka hoʻokolohua makapō makapō makapō ma ka lawelawe perioperative o nā probiotics i nā mea maʻi maʻi maʻi colorectal. Honua J Gastroenterol. 1-14-2010; 16: 167-175. Nānā kiʻi ʻole.
106. Andrade, S. a me Borges, N. Ka hopena o ka waiū hū i piha me Lactobacillus acidophilus a me Bifidobacterium longum ma nā lipid plasma o nā wahine me ka cholesterol maʻamau a kaulike paha. ʻO J.Dairy Res. 2009; 76: 469-474. Nānā kiʻi ʻole.
107. Rouge, C., Piloquet, H., Butel, MJ, Berger, B., Rochat, F., Ferraris, L., Des, Robert C., Legrand, A., de la Cochetiere, MF, N'Guyen, ʻO JM, Vodovar, M., Voyer, M., Darmaun, D., a me Roze, ʻo JC Oral supplementation me nā probiotics i nā pēpē preterm pēpē haʻahaʻa loa: kahi hoʻokolohua i hoʻokolohua ʻole ʻia, pālua makapō, kahi hoʻokolokolo. ʻO Am.J Clin.Nutr. 2009; 89: 1828-1835. Nānā kiʻi ʻole.
108. Iwabuchi, N., Takahashi, N., Xiao, JZ, Yonezawa, S., Yaeshima, T., Iwatsuki, K., a me Hachimura, S. Nā hopena kūpikipiki o Bifidobacterium longum i ka hana ʻana o Th2-ʻumeʻume chemokine i hoʻokomo ʻia me T hoʻolauna pūnaewele pūnaewele ʻO FEMS Immunol.Med.Microbiol. 2009; 55: 324-334. Nānā kiʻi ʻole.
109. Takeda, Y., Nakase, H., Namba, K., Inoue, S., Ueno, S., Uza, N., a me Chiba, T. Hoʻohālikelike ʻia o T-bet a me nā mole paʻa paʻa e Bifidobactrium longum e hoʻomaikaʻi ai i ka mumū kolona. o ka ulcerative colitis. Inflamm. Pūlua. 2009; 15: 1617-1618. Nānā kiʻi ʻole.
110. Soh, SE, Aw, M., Gerez, I., Chong, YS, Rauff, M., Ng, YP, Wong, HB, Pai, N., Lee, BW, a me Shek, LP Probiotic supplementation in the first 6 mau mahina o ke ola i ka pilikia o nā pēpē Asia - nā hopena ma ka eczema a me ka atopic sensitization i ka makahiki 1. ʻO Clin.Exp. Allergy 2009; 39: 571-578. Nānā kiʻi ʻole.
111. Odamaki, T., Xiao, JZ, Sakamoto, M., Kondo, S., Yaeshima, T., Iwatsuki, K., Togashi, H., Enomoto, T., a me Benno, Y. Ka puʻunaue ʻana i nā ʻano like ʻole o ka ʻO ka Bacteroides fragilis pūʻulu i loko o kēlā me kēia kanaka me nā polinela lāʻau kedera Kepani. Appl.En environment.Microbiol. 2008; 74: 6814-6817. Nānā kiʻi ʻole.
112. del Giudice, M. M. a me Brunese, F. P. Probiotics, prebiotics, a me nā maʻi āpau i nā keiki: he aha ka mea hou i ka makahiki i hala? ʻO J Clin.Gastroenterol. 2008; 42 Hōʻailona 3 Pt 2: S205-S208. Nānā kiʻi ʻole.
113. Chouraqui, JP, Grathwohl, D., Labaune, JM, Hascoet, JM, de, Montgolfier, I, Leclaire, M., Giarre, M., a me Steenhout, P. Nānā i ka palekana, ke ahonui, a me nā hopena pale i ka maʻi palahā. o nā hana pēpē pēpē me nā huikau o nā probiotics a i ʻole nā ​​probiotics a me nā prebiotics i kahi hoʻokolokolo hoʻokolohua kaulike ʻia. ʻO Am.J Clin.Nutr. 2008; 87: 1365-1373. Nānā kiʻi ʻole.
114. ʻO Matsumoto, T., Ishikawa, H., Tateda, K., Yaeshima, T., Ishibashi, N., a me Yamaguchi, K. ʻO ka lawelawe waha ʻana o Bifidobacterium longum e pale i ka Pseudomonas aeruginosa sepsis i loaʻa i ka ʻōpū i nāʻiole. ʻO J Appl.Microbiol. 2008; 104: 672-680. Nānā kiʻi ʻole.
115. Odamaki, T., Xiao, JZ, Iwabuchi, N., Sakamoto, M., Takahashi, N., Kondo, S., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, T., a ʻO Benno, Y. Ka hopena o ka Bifidobacterium longum BB536 i lawe ʻia ma microbiota faecal i kēlā me kēia kanaka me nā pollinosis lāʻau Kepanī i ka wā o ka pollen. ʻO J Med.Microbiol. 2007; 56 (Pt 10): 1301-1308. Nānā kiʻi ʻole.
116. Iwabuchi, N., Takahashi, N., Xiao, J. Z., Miyaji, K., a me Iwatsuki, K. In vitro Th1 cytokine-kūʻokoʻa Th2 suppressive effects of bifidobacteria. Microbiol.Immunol. 2007; 51: 649-660. Nānā kiʻi ʻole.
117. Xiao, JZ, Kondo, S., Takahashi, N., Odamaki, T., Iwabuchi, N., Miyaji, K., Iwatsuki, K., a me Enomoto, T. Nā loli i ka pae plasma TARC i ka wā pollen lāʻau kedera Iapana a nā pilina me ka hoʻomohala ʻōuli. Int. ʻArch. Immunol Allergy. 2007; 144: 123-127. Nānā kiʻi ʻole.
118. Odamaki, T., Xiao, JZ, Iwabuchi, N., Sakamoto, M., Takahashi, N., Kondo, S., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, T., a ʻO Benno, Y. Ka piʻi ʻana o ka microbiota fecal i kēlā me kēia kanaka me nā polinela lāʻau kedera Kepani i ka wā o ka pollen a me ka hopena o ka lawe probiotic. ʻO J Investig. Allergol.Clin.Immunol. 2007; 17: 92-100. Nānā kiʻi ʻole.
119. Xiao, JZ, Kondo, S., Yanagisawa, N., Miyaji, K., Enomoto, K., Sakoda, T., Iwatsuki, K., a me Enomoto, T. ʻO ka pono o ka probiotic Bifidobacterium longum no ka mālama ʻana i nā ʻōuli. o nā alemania pollen lāʻau kedera Kepani i nā kumuhana i loiloi ʻia i loko o kahi ʻike kūlohelohe. Allergol.Int. 2007; 56: 67-75. Nānā kiʻi ʻole.
120. ʻO Puccio, G., Cajozzo, C., Meli, F., Rochat, F., Grathwohl, D., a me Steenhout, P. Loiloi loiloi i kahi ʻōnaehana hoʻomaka hou no nā pēpē i loko o Bifidobacterium longum BL999 a me prebiotics Nutr 2007; 23: 1-8. Nānā kiʻi ʻole.
121. Xiao, JZ, Kondo, S., Yanagisawa, N., Takahashi, N., Odamaki, T., Iwabuchi, N., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, K., a ʻO Enomoto, T. Probiotics i ka mālama ʻana i nā pollinosis lāʻau kedera Kepani: kahi hoʻokolokolo placebo-kāohi makapō makapō. ʻO Clin.Exp. Allergy 2006; 36: 1425-1435. Nānā kiʻi ʻole.
122. Xiao, JZ, Kondo, S., Yanagisawa, N., Takahashi, N., Odamaki, T., Iwabuchi, N., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, K., a ʻO Enomoto, T. Ka hopena o ka probiotic Bifidobacterium longum BB536 [i hoʻoponopono ʻia] i ka hoʻokuʻu ʻana i nā ʻōuli maʻi a me ka hoʻoliʻiliʻi ʻana i nā pae cytokine plasma o ka lāʻau kedera Kepanī i ka wā pollen. ʻO ka hoʻokolohua makapō makapō, kahi hoʻokolokolo. ʻO J Investig. Allergol.Clin.Immunol. 2006; 16: 86-93. Nānā kiʻi ʻole.
123. ʻO Bennet, R., Nord, C. E., a me Zetterstrom, R. Noho kuʻuna o ka ʻōpū o nā pēpē hānau hou e nā waha ʻo bifidobacteria a me lactobacilli. ʻO Acta Paediatr. 1992; 81: 784-787. Nānā kiʻi ʻole.
124. Zsivkovits, M., Fekadu, K., Sontag, G., Nabinger, U., Huber, WW, Kundi, M., Chakraborty, A., Foissy, H., a me Knasmuller, S. Kāohi ʻana i ka heterocyclic amine ʻO ka hōʻino ʻia o DNA ma ke kolona a me ke ake o nā ʻiole e nā ʻano lactobacillus ʻokoʻa. Carcinogenesis 2003; 24: 1913-1918. Nānā kiʻi ʻole.
125. Orrhage, K., Sjostedt, S., a me Nord, C. E. Ka hopena o nā mea hoʻopihapiha me ka bacteria acid lactic a me ka oligofructose ma ka microflora ʻōpū i ka manawa o ka cefpodoxime proxetil. ʻO J Antimicrob.Chemother. 2000; 46: 603-612. Nānā kiʻi ʻole.
126. Xiao JZ, Takahashi S, Odamaki T, et al. ʻO ka antibiotic susceptibility o nā ʻano bifidobacterial i hāʻawi ʻia i ka mākeke Iapana.ʻO Biosci Biotechnol Biochem. 2010; 74: 336-42. Nānā kiʻi ʻole.
127. AlFaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics no ka pale ʻana i ka enterrotrotrot necrotizing i nā pēpē preterm. ʻO Cochrane Hōkeo ʻikepili o nā Manaʻo Pūnaewele 2011, Hoʻopuka 3. Art. ʻAʻole .: CD005496. DOI: 10.1002 / 14651858.CD005496.pub3. Nānā kiʻi ʻole.
128. Tabbers MM, Milliano I, Roseboom MG, Benninga MA. Hana maikaʻi ʻo Bifidobacterium breve i ka mālama ʻana i ka paʻa o ke keiki? Nā hualoaʻa mai kahi noiʻi pilote. Nutr J 2011; 10:19. Nānā kiʻi ʻole.
129. ʻO Leyer GJ, Li S, Mubasher ME, et al. Nā hopena Probiotic ma ke anu a me ka maʻi influenza-like a me ka lōʻihi o nā keiki. Nā Pediatrics 2009; 124: e172-e179. Nānā kiʻi ʻole.
130. Miele E, Pascarella F, Giannetti E. et al. Ka hopena o kahi hoʻomākaukau probiotic (VSL # 3) ma ka hoʻokomo a me ka mālama ʻana i ke kala ʻana i nā keiki me ka colitis ulcerative. Am J Gastroenterol 2009; 104: 437-43. Nānā kiʻi ʻole.
131. Kuhbacher T, Ott SJ, Helwig U, et al. ʻO microbiota bacteria a me fungal e pili ana i ka probiotic therapy (VSL # 3) i ka pouchitis. ʻO Gut 2006; 55: 833-41. Nānā kiʻi ʻole.
132. Bibiloni R, Fedorak RN, Tannock GW, a me al. VSL # 3 probiotic-hoʻohuihui induces remission i nā mea maʻi me ka hana ulcerative colitis. ʻO Am J Gastroenterol 2005; 100: 1539-46. Nānā kiʻi ʻole.
133. ʻO Tursi A, Brandimarte G, Giorgetti GM, et al. ʻOi aku ka maikaʻi o ka hoʻomākaukau probiotic haʻahaʻa ma mua o ka balsalazide a i ʻole mesalazine i ka mālama ʻana i ka colitis ulcerative ulcerative akahai. Med Sci Monit 2004; 10: PI126-31. Nānā kiʻi ʻole.
134. Kato K, Mizuno S, Umesaki Y, et al. ʻO ka hoʻāʻo ʻana i kahi placebo-kāohi ʻia e nānā ana i ka hopena o ka waiū bifidobacteria-fermented ma ka colitis ulcerative colitis. Aliment Pharmacol Ther 2004; 20: 1133-41. Nānā kiʻi ʻole.
135. McFarland LV. Meta-Ka Ikepili o nā probiotics no ka pale ʻana i nā maʻi ʻalopiki e pili ana i ka maʻi diarrhea a me ka mālama ʻana i ka maʻi Clostridium difficile. 'Am J Gastroenterol 2006; 101: 812-22. Nānā kiʻi ʻole.
136. O'Mahony L, McCarthy J, Kelly P, et al. ʻO Lactobacillus a me bifidobacterium i ka maʻi hanu huhū: nā pane ʻōuli a me ka pilina i nā moʻolelo cytokine. ʻO Gastroenterology 2005; 128: 541-51. Nānā kiʻi ʻole.
137. Ishikawa H, Akedo I, Umesaki Y, et al. Hoʻomaʻamaʻa kaulike ʻia i ka hopena o ka waiū bifidobacteria-fermented ma ka ulcerative colitis. ʻO J Am Coll Nutr 2003; 22: 56-63. Nānā kiʻi ʻole.
138. ʻO Rastall RA. ʻO ke koʻohune i ka ʻōpū: nā hoaaloha a me nā ʻenemi a pehea e hoʻololi ai i ke kaulike. ʻO J Nutr 2004; 134: 2022S-2026S. Nānā kiʻi ʻole.
139. Mimura T, Rizzello F, Helwig U, et al. I ka manawa o kēlā me kēia lā probiotic dose (VSL # 3) kiʻekiʻe no ka mālama ʻana i ke kala ʻana i ka pouchitis recurrent a i ʻole refactory. ʻO Gut 2004; 53: 108-14. Nānā kiʻi ʻole.
140. Cremonini F, Di Caro S, Covino M, et al. Ka hopena o nā hoʻomākaukau probiotic ʻokoʻa ma nā hopena ʻē aʻe e pili ana i ka anti-helobobacter pylori therapy: kahi hui like, ʻekolu mau makapō, kahi noiʻi ʻia me kahi placebo. 'Am J Gastroenterol 2002; 97: 2744-9. Nānā kiʻi ʻole.
141. ʻO Sullivan A, Barkholt L, Nord CE. ʻO Lactobacillus acidophilus, Bifidobacterium lactis a me Lactobacillus F19 e ​​pale aku i nā haunaele e pili ana i ka lāʻau antibiotic o Bacteroides fragilis i loko o ka ʻōpū. ʻO J Antimicrob Chemother 2003; 52: 308-11. Nānā kiʻi ʻole.
142. Kim HJ, Camilleri M, McKinzie S, et al. ʻO kahi hoʻokolohua hoʻokolohua kaulike ʻia o kahi probiotic, VSL # 3, ma ke kahe ʻana o ka ʻōpū a me nā ʻōuli i ka maʻi pākī nui loa o ka diarrhea. Aliment Pharmacol Ther 2003; 17: 895-904. . Nānā kiʻi ʻole.
143. Roberfroid MB. Nā Prebiotics a me nā probiotics: he meaʻai kūpono paha ia? 'Am J Clin Nutr 2000; 71: 1682S-7S. Nānā kiʻi ʻole.
144. ʻO Gionchetti P, Rizzello F, Venturi A, et al. ʻO ka bacteriotherapy oral ma ke ʻano he mālama mālama i nā mea maʻi me ka pouchitis mau loa: kahi makapō makapō, kahi hoʻokolokolo i kaohi ʻia e ka placebo. Gastroenterology 2000; 119: 305-9. Nānā kiʻi ʻole.
145. Rautio M, Jousimies-Somer H, Kauma H, et al. Hewa abscess ma muli o Lactobacillus rhamnosus kānana ʻike ʻole ʻia mai ka L. rhamnosus kānana GG. ʻOhana Infect Dis 1999; 28: 1159-60. Nānā kiʻi ʻole.
146. ʻO Goldin BR. Nā pono olakino o nā probiotics. Br J Nutr 1998; 80: S203-7. Nānā kiʻi ʻole.
147. Kalima P, Masterton RG, Roddie PH, et al. ʻO ka maʻi Lactobacillus rhamnosus i kahi keiki e pili ana i ka hoʻoneʻe ʻana o ka iwi iwi. ʻO J Infect 1996; 32: 165-7. Nānā kiʻi ʻole.
148. Saxelin M, Chuang NH, Chassy B, et al. ʻO Lactobacilli a me bacteremia ma ka hema o 1989-1992. ʻO Clin Infect Dis 1996; 22: 564-6. Nānā kiʻi ʻole.
149. Lewis SJ, Freedman AR. ʻO ka ʻatikala nānā: ka hoʻohana ʻana o nā mea ola biotherapeutic i ka pale a me ka mālama ʻana i ka maʻi gastrointestinal. Aliment Pharmacol Ther 1998; 12: 807-22. Nānā kiʻi ʻole.
150. Meydani SN, Ha WK. Nā hopena Immunologic o yogurt. 'Am J Clin Nutr 2000; 71: 861-72. Nānā kiʻi ʻole.
151. Isolauri E, Arvola T, Sutas Y, et al. Probiotics i ka mālama ʻana i ka atopic eczema. ʻO Clin Exp Allergy 2000; 30: 1604-10. Nānā kiʻi ʻole.
152. Korschunov VM, Smeyanov VV, Efimov BA, et al. Hoʻohana Therapeutic o kahi hoʻomākaukau antibiotic-resistive Bifidobacterium i nā kāne i kū i ka gamma-irradiation kiʻekiʻe. ʻO J Med Microbiol 1996; 44: 70-4. Nānā kiʻi ʻole.
153. Venturi A, Gionchetti P, Rizzello F, et al. Ka hopena ma ka hanana o ka flora faecal e kahi hoʻomākaukau probiotic hou: ʻike mua i ka mālama ʻana i nā mea maʻi me ka colitis ulcerative. Aliment Pharmacol Ther 1999; 13: 1103-8. Nānā kiʻi ʻole.
154. Phuapradit P, Varavithya W, Vathanophas K, et al. Ka hoʻoliʻiliʻi o ka maʻi rotavirus i nā keiki e loaʻa ana i ka pāʻālua bifidobacteria-supplement. ʻO J Med Assoc Thai 1999; 82: S43-8. Nānā kiʻi ʻole.
155. Hoyos AB. Hoʻemi ʻia ka hanana o ka necrotizing enterocolitis e pili ana me ka enteral administration o Lactobacillus acidophilus a me Bifidobacterium infantis i neonates i kahi keʻena mālama nui. ʻO Int J Infect Dis 1999; 3: 197-202. Nānā kiʻi ʻole.
156. ʻO Pierce A. Ke alakaʻi lāʻau pono ʻAmelika ʻAmelika i nā lāʻau lapaʻau kūlohelohe. Nu Ioka: Ka Papa Paʻi ʻo Stonesong, 1999: 19.
157. Chen RM, Wu JJ, Lee SC, et al. Ka hoʻonui ʻana o ka Bifidobacterium ʻōpū a me ka kaohi ʻana i nā koʻohune coliform me ka lawe ʻana i ka yogurt manawa pōkole. ʻO J Dairy Sci 1999: 82: 2308-14. Nānā kiʻi ʻole.
158. Ha GY, Yang CH, Kim H, Chong Y. Ke kumu o ka sepsis i hoʻokumu ʻia e Bifidobacterium longum. ʻO J Clin Microbiol 1999; 37: 1227-8. Nānā kiʻi ʻole.
159. ʻO Colombel JF, Cortot A, Neut C, Romond C. Yoghurt me Bifidobacterium longum e hoʻoliʻiliʻi i nā hopena gastrointestinal erythromycin. Lancet 1987; 2:43.
160. Hirayama K, R After J. Ke kuleana o ka bacteria koʻokoʻo probiotic i ka pale ʻana i ka maʻi ʻaʻa. Nā Maʻemaʻe Microbes 2000; 2: 681-6. Nānā kiʻi ʻole.
161. Macfarlane GT, Cummings JH. Nā Probiotics a me nā prebiotics: hiki i ke kaohi ʻana i nā hana o ke koʻohune ʻōpū ke hoʻopōmaikaʻi i ke olakino? BMJ 1999; 318: 999-1003. Nānā kiʻi ʻole.
162. Chiang BL, Sheih YH, Wang LH, et al. Hoʻonui i ka pale ʻana ma o kaʻai ʻana o ka dietiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization a me ka wehewehe ʻana o nā pane pale pale paʻa pūnaewele. Eur J Clin Nutr 2000; 54: 849-55. Nānā kiʻi ʻole.
163. Lievin V, Peiffer I, Hudault S, et al. Hana nā ʻano Bifidobacterium mai nā kamaiki kamaiki gastrointestinal microflora i ka hana antimicrobial. ʻO Gut 2000; 47: 646-52. Nānā kiʻi ʻole.
164. ʻO Arunachalam K, Gill HS, Chandra RK. Hoʻonui i ka hana kūlohelohe maoli e kaʻai papaʻai o Bifidobacterium lactis (HN019). Eur J Clin Nutr 2000; 54: 263-7. Nānā kiʻi ʻole.
165. Bouhnik Y, Pochart P, Marteau P, et al. ʻO ka hoʻōla hou i nā kānaka o ka bifidobacterium hiki ke ʻai ʻia i ka waiū hū. ʻO Gastroenterology 1992; 102: 875-8. Nānā kiʻi ʻole.
166. Saavedra JM, et al. ʻO ka hānai ʻana i ka bifidobacterium bifidum a me ka streptococcus thermophilus i nā pēpē i ka haukapila no ka pale ʻana i ka maʻi diarrhea a me ka hoʻokahe ʻana o rotavirus. Lancet 1994; 344: 1046-9. Nānā kiʻi ʻole.
167. ʻO Scarpignato C, Rampal P. Kāohi a me ka mālama ʻana i ka maʻi diarrhea o ka mea huakaʻi. Chemotherapy 1995; 41: 48-81. Nānā kiʻi ʻole.
168. ʻO Elmer GW, Surawicz CM, McFarland LV. Nā Biotherapeutic Agents, kahi hana maʻamau i mālama ʻole ʻia no ka mālama ʻana a me ka pale ʻana i nā maʻi ʻōpū a me nā maʻi puʻupuʻu i koho ʻia. ʻO JAMA 1996; 275: 870-5. Nānā kiʻi ʻole.

Nānā hope - 11/25/2020